{"mainPropery":{"diseaseId":4071,"diseaseName":"Spinocerebellar ataxia 1","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4071/spinocerebellar-ataxia-1","synonyms":["SCA1","Spinocerebellar ataxia type 1","Olivopontocerebellar atrophy 1","OPCA1","Cerebelloparenchymal disorder 1","Menzel type OPCA","Olivopontocerebellar atrophy 4","OPCA4","Schut-Haymaker type OPCA","Spinocerebellar atrophy 1"],"synonyms-with-source":[{"name":"SCA1"},{"name":"Spinocerebellar ataxia type 1"},{"name":"Olivopontocerebellar atrophy 1"},{"name":"OPCA1"},{"name":"Cerebelloparenchymal disorder 1"},{"name":"Menzel type OPCA"},{"name":"Olivopontocerebellar atrophy 4"},{"name":"OPCA4"},{"name":"Schut-Haymaker type OPCA"},{"name":"Spinocerebellar atrophy 1"}],"identifiers":[{"identifierType":"OMIM","identifierId":"164400"},{"identifierType":"ORPHANET","identifierId":"98755"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":44,"resourceName":"National Ataxia Foundation","abbreviation":"","address1":"600 Highway 169 South","address2":"Suite 1725","address3":"","address4":"","address5":"","city":"Minneapolis","state":"MN","zip":"55426","country":"United States","phone":"+1-763-553-0020","tty":"","tollFree":"","fax":"+1-763-553-0167","email":"naf@ataxia.org","url":"https://ataxia.org/","freeText":""},{"resourceID":46,"resourceName":"euro-ATAXIA (European Federation of Hereditary Ataxias)","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.euroataxia.org/","freeText":""},{"resourceID":403,"resourceName":"Ataxia UK","abbreviation":"","address1":"12 Broadbent Close ","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":" N6 5JW","country":"United Kingdom","phone":"020 7582 1444 ","tty":"","tollFree":"0845 644 0606 (Helpline)","fax":"","email":"helpline@ataxia.org.uk","url":"https://www.ataxia.org.uk/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/164400' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=164400' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Spinocerebellar ataxia 1. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Spinocerebellar+ataxia+1%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Spinocerebellar ataxia 1. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/spinocerebellar-ataxia-type-1' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Spinocerebellar ataxia 1. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1110,"resourceId":1792,"resourceName":"Univ Washington - testing for spinocerebellar ataxias","descriptionText":"<a href='http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf' target='_blank'>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</a> is a booklet providing information about spinocerebellar ataxia and is available as a PDF document on the University of Washington Medical Center Web site. Click on the title above to view this resource.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0752120' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022500' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1533,"resourceId":2164,"resourceName":"National Center for Biotechnology Information","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gnd&part=spinocerebellarataxia' target='_blank'>National Center for Biotechnology Information</a> (NCBI) was established in 1988 as a national resource for molecular biology information.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98755' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=sca1#sca1' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merck.com/mmpe/sec16/ch221/ch221j.html#sec16-ch221-ch221j-182' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1892,"resourceId":44,"resourceName":"National Ataxia Foundation","descriptionText":"The <a href='https://ataxia.org/neurologists-and-specialty-clinics/#AtaxiaClinics' target='_blank'>National Ataxia Foundation</a>, a nonprofit organization dedicated to improving the lives of persons affected by ataxia, provides lists of neurologists, ataxia clinics, and movement disorder clinics.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2076,"resourceId":2843,"resourceName":"Coordination of Rare Diseases at Sanford (CoRDS)","descriptionText":"<a href='http://www.sanfordresearch.org/cords/patientsfamilies/' target='_blank'>Coordination of Rare Diseases at Sanford (CoRDS)</a> hosts a specific registry for patients with ataxia in partnership with the National Ataxia Foundation. The goal of the CoRDS registry is to connect as many patients and researchers as possible to help advance treatments and cures for rare diseases. The CoRDS registry is free for patients to enroll and for researchers to access.","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:164400' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":10171,"questionText":"What is spinocerebellar ataxia 1?","answerText":"<strong>Spinocerebellar ataxia type 1</strong> (SCA1) is a progressive\r\nmovement disorder that typically begins in early adulthood (but can\r\naffect children and older adults as well). Early signs and symptoms\r\nincludes problems with coordination and balance (ataxia), speech and\r\nswallowing difficulties, muscle stiffness,  and weakness in the muscles\r\nthat control eye movement. Over time, SCA1 may cause mental impairment,\r\nnumbness, tingling, or pain in the arms and legs and uncontrolled muscle\r\ntensing, wasting, and twitches. SCA1 is caused by changes in the ATXN1\r\ngene and is inherited in an <a target=\"_blank\" href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\">autosomal dominant</a> fashion. There is\r\ncurrently not a cure for SCA1, but treatments are available to help\r\nmanage symptoms. People with SCA1 typically survive 10 to 30 years after\r\nsymptoms first appear.[10722][8311]","dateModified":"2016-02-24T13:32:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":12858,"relatedDiseaseName":"Autosomal Dominant Cerebellar Ataxias","relation":"Parent","isRare":false,"hasGardPage":false},{"relatedDiseaseId":6614,"relatedDiseaseName":"Hereditary ataxia","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10748,"relatedDiseaseName":"Spinocerebellar ataxia","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":55336,"abbreviatedInquiry":"Is it common to have bowel problems when you have SCA1?","caseQuestions":[{"questionId":10171,"questionText":"What is spinocerebellar ataxia 1?","answerText":"<strong>Spinocerebellar ataxia type 1</strong> (SCA1) is a progressive\r\nmovement disorder that typically begins in early adulthood (but can\r\naffect children and older adults as well). Early signs and symptoms\r\nincludes problems with coordination and balance (ataxia), speech and\r\nswallowing difficulties, muscle stiffness,  and weakness in the muscles\r\nthat control eye movement. Over time, SCA1 may cause mental impairment,\r\nnumbness, tingling, or pain in the arms and legs and uncontrolled muscle\r\ntensing, wasting, and twitches. SCA1 is caused by changes in the ATXN1\r\ngene and is inherited in an <a target=\"_blank\" href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\">autosomal dominant</a> fashion. There is\r\ncurrently not a cure for SCA1, but treatments are available to help\r\nmanage symptoms. People with SCA1 typically survive 10 to 30 years after\r\nsymptoms first appear.[10722][8311]","dateModified":"2016-02-24T13:32:00","references":[{"referenceId":8311,"authors":"Bird TD","articleTitle":"Hereditary Ataxia Overview","bookWebsiteJournalTitle":"GeneReviews","date":"November 26, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1138/","dateAccessed":"2015-02-17T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10722,"authors":"","articleTitle":"Spinocerebellar ataxia type 1","bookWebsiteJournalTitle":"Genetic Home Reference","date":"Reviewed February 2011","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/spinocerebellar-ataxia-type-1","dateAccessed":"2016-02-24T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10723,"authors":"","articleTitle":"Frequently asked questions about sporadic ataxia and multiple system atrophy (MSA)","bookWebsiteJournalTitle":"National Ataxia Foundation","date":"","volume":"","pages":"","url":"https://www.ataxia.org/pdf/Sporadic.pdf","dateAccessed":"2016-02-24T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10724,"authors":"Mähler A et al.,","articleTitle":"Increased catabolic state in spinocerebellar ataxia type 1 patients","bookWebsiteJournalTitle":"Cerebellum","date":"2014 Aug","volume":"13(4)","pages":"440-6","url":"","dateAccessed":"2016-02-24T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10172,"questionText":"<strong>Does spinocerebellar ataxia type 1 often cause bowel problems?</strong>","answerText":"Bowel problems (such as constipation) is a common problem for people who\r\nhave medical conditions which result in reduce activity. The National\r\nAtaxia Foundation offers information on nutrition for people with\r\nprogressive central nervous system disease, which includes information\r\non managing irregular bowel movements. To view the article visit: <a tabindex=\"-1\" href=\"http://www.ataxia.org/pdf/Nutrition_and_the_Patient_with_Progressive_Central_Nervous_System_Disease.pdf\" target=\"_blank\">http://www.ataxia.org/pdf/Nutrition_and_the_Patient_with_Progressive_Central_Nervous_System_Disease.pdf</a><br />\r\n<br />\r\nIn addition, some people with spinocerebellar ataxia develop problems\r\nwith their autonomic nervous system. The autonomic nervous system\r\ncontrols the automatic functioning of the body, such as regulating blood\r\npressure, digestion, sweating, some sexual functions, and the bladder\r\nand bowel.[10723][10724]","dateModified":"2016-02-24T13:33:00","references":[{"referenceId":10723,"authors":"","articleTitle":"Frequently asked questions about sporadic ataxia and multiple system atrophy (MSA)","bookWebsiteJournalTitle":"National Ataxia Foundation","date":"","volume":"","pages":"","url":"https://www.ataxia.org/pdf/Sporadic.pdf","dateAccessed":"2016-02-24T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10724,"authors":"Mähler A et al.,","articleTitle":"Increased catabolic state in spinocerebellar ataxia type 1 patients","bookWebsiteJournalTitle":"Cerebellum","date":"2014 Aug","volume":"13(4)","pages":"440-6","url":"","dateAccessed":"2016-02-24T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13460,"phenoTypeName":"Progressive cerebellar ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9639,"phenoTypeName":"Abnormal flash visual evoked potentials","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":409,"phenoTypeName":"Abnormal nerve conduction velocity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":831,"phenoTypeName":"Abnormality of somatosensory evoked potentials","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13687,"phenoTypeName":"Atrophy/Degeneration affecting the brainstem","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13456,"phenoTypeName":"Bradykinesia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5212,"phenoTypeName":"Bulbar signs","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8731,"phenoTypeName":"Cerebellar atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13706,"phenoTypeName":"Chorea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15349,"phenoTypeName":"Inertia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12120,"phenoTypeName":"Loss of Purkinje cells in the cerebellar vermis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11437,"phenoTypeName":"Memory impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5622,"phenoTypeName":"Slow saccadic eye movements","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5658,"phenoTypeName":"Slurred speech","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12454,"phenoTypeName":"Staring gaze","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3797,"phenoTypeName":"Upgaze palsy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1161,"phenoTypeName":"Abnormality of masticatory muscle","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13708,"phenoTypeName":"Dysdiadochokinesis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9396,"phenoTypeName":"Dysmetria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5156,"phenoTypeName":"Fasciculations","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13822,"phenoTypeName":"Gait imbalance","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3510,"phenoTypeName":"Hyperactive deep tendon reflexes","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13669,"phenoTypeName":"Hypermetric saccades","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8725,"phenoTypeName":"Hyporeflexia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5101,"phenoTypeName":"Impaired proprioception","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9180,"phenoTypeName":"Ophthalmoparesis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13849,"phenoTypeName":"Postural tremor","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4292,"phenoTypeName":"Respiratory failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4502,"phenoTypeName":"Decreased amplitude of sensory action potentials","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13561,"phenoTypeName":"Decreased motor nerve conduction velocity","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13567,"phenoTypeName":"Decreased sensory nerve conduction velocity","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13705,"phenoTypeName":"Abnormality of extrapyramidal motor function","percentRanges":"-"},{"phenoTypeId":6254,"phenoTypeName":"Adult onset","percentRanges":"-"},{"phenoTypeId":8737,"phenoTypeName":"Areflexia","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","percentRanges":"-"},{"phenoTypeId":9377,"phenoTypeName":"Bulbar palsy","percentRanges":"-"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","percentRanges":"-"},{"phenoTypeId":13870,"phenoTypeName":"Dilated fourth ventricle","percentRanges":"-"},{"phenoTypeId":5271,"phenoTypeName":"Distal amyotrophy","percentRanges":"-"},{"phenoTypeId":9795,"phenoTypeName":"Dorsal column degeneration","percentRanges":"-"},{"phenoTypeId":10111,"phenoTypeName":"Dysmetric saccades","percentRanges":"-"},{"phenoTypeId":10110,"phenoTypeName":"Gaze-evoked nystagmus","percentRanges":"-"},{"phenoTypeId":5314,"phenoTypeName":"Genetic anticipation with paternal anticipation bias","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":3052,"phenoTypeName":"Impaired horizontal smooth pursuit","percentRanges":"-"},{"phenoTypeId":14292,"phenoTypeName":"Impaired vibratory sensation","percentRanges":"-"},{"phenoTypeId":13459,"phenoTypeName":"Limb ataxia","percentRanges":"-"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","percentRanges":"-"},{"phenoTypeId":14223,"phenoTypeName":"Olivopontocerebellar atrophy","percentRanges":"-"},{"phenoTypeId":5651,"phenoTypeName":"Optic disc pallor","percentRanges":"-"},{"phenoTypeId":13843,"phenoTypeName":"Scanning speech","percentRanges":"-"},{"phenoTypeId":8711,"phenoTypeName":"Spasticity","percentRanges":"-"},{"phenoTypeId":13635,"phenoTypeName":"Spinocerebellar atrophy","percentRanges":"-"},{"phenoTypeId":14293,"phenoTypeName":"Spinocerebellar tract degeneration","percentRanges":"-"},{"phenoTypeId":10097,"phenoTypeName":"Supranuclear ophthalmoplegia","percentRanges":"-"},{"phenoTypeId":13711,"phenoTypeName":"Truncal ataxia","percentRanges":"-"},{"phenoTypeId":7928,"phenoTypeName":"Urinary bladder sphincter dysfunction","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Spinocerebellar_ataxia_1"}